Skip to main content
. 2022 Jun;28(6):1170–1179. doi: 10.3201/eid2806.211335

Table 5. Societal perspective of total cost of Lyme disease per participant, by disease category, in high-incidence areas, United States, 2014–2016.

Disease category
No. participants
Societal perspective, total cost per participant,* 2016 US dollars
Median
Mean
SD
10th percentile
90th percentile
Range
All† 613 690 2,032 6,091 203 4,201 54–122,766
Confirmed localized 273 493 1,307 3,559 154 2,678 54–18,322
Confirmed disseminated 154 1,081 3,251 20,908 297 6,238 216–122,766
Probable 186 940 2,620 15,533 316 5,021 130–105,500

*Total cost per participant according to the societal perspective includes societal medical costs, patient nonmedical costs, and cost of productivity losses. Patient medical costs were not added because they are already included in societal medical costs. †Estimates for the overall population use the sample-weighted data except the range.